Within a week of diagnosis, individuals who developed asymptomatic or mild COVID-19 could be distinguished by significantly increased mucosal IP-10 and decreased systemic IL-1RA, MIP-1β, IL-6, fractalkine, IgA, and IgM within one week of positive diagnostic (Fig. 6A and C). The gene discussed is CD79A; the disease is COVID-19.